How big is SINTX Technologies, Inc.?

As of Jun 18, SINTX Technologies, Inc. has a market capitalization of 8.38 million, with net sales of 2.57 million and a net profit of -12.43 million over the latest four quarters. Shareholder's funds are 3.89 million, and total assets amount to 9.41 million.

As of Jun 18, SINTX Technologies, Inc. has a market capitalization of 8.38 million, categorizing it as a Micro Cap company.<BR><BR>As of Jun 18, the sum of net sales for the latest four quarters is 2.57 million, while the sum of net profit for the same period is -12.43 million.<BR><BR>As of Dec 24, the reporting period shows shareholder's funds of 3.89 million and total assets amounting to 9.41 million.

What does SINTX Technologies, Inc. do?

SINTX Technologies, Inc. is a biomaterial company specializing in silicon nitride orthopedic medical devices. As of March 2025, it reported net sales of $0 million and a net loss of $2 million, with a market cap of $8.38 million.

Overview:<BR>SINTX Technologies, Inc. is a commercial biomaterial company in the Pharmaceuticals & Biotechnology industry, focused on developing and manufacturing silicon nitride orthopedic medical devices.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 0 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -2 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 8.38 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: -0.99 <BR>Return on Equity: -133.70% <BR>Price to Book: 1.38<BR><BR>Contact Details:<BR>Address: 1885 West 2100 Street, SALT LAKE CITY UT: 84119 <BR>Tel: ['1 801 8393516', '1 801 8393534'] <BR>Fax: 1 801 8393605 <BR>Website: https://sintx.com/

Should I buy, sell or hold SINTX Technologies, Inc.?

Who are in the management team of SINTX Technologies, Inc.?

As of March 2022, the management team of SINTX Technologies, Inc. is led by Dr. B. Sonny Bal, who is the Chairman, President, CEO, and CFO, alongside independent directors Mr. Mark Froimson, Mr. Eric Stookey, Mr. David Truetzel, and Mr. Jeffrey White.

As of March 2022, the management team of SINTX Technologies, Inc. includes Dr. B. Sonny Bal, who serves as the Chairman of the Board, President, Chief Executive Officer, and Chief Financial Officer. Additionally, the board features several independent directors: Mr. Mark Froimson, Mr. Eric Stookey, Mr. David Truetzel, and Mr. Jeffrey White.

Is SINTX Technologies, Inc. overvalued or undervalued?

As of March 29, 2023, SINTX Technologies, Inc. is rated as risky due to overvaluation and poor financial metrics, including a negative P/E ratio of -1.6293, despite a recent strong 1-month return of 32.70%, which still underperformed compared to the S&P 500's 2.33% return.

As of 29 March 2023, the valuation grade for SINTX Technologies, Inc. has moved from does not qualify to risky, indicating a heightened level of concern regarding its financial health. The company appears to be overvalued given its negative performance metrics, including a Price to Book Value of 1.17, an EV to Sales ratio of 0.43, and a staggering ROCE of -822.40%. <BR><BR>In comparison to its peers, SINTX Technologies has a P/E ratio of -1.6293, while Vivos Therapeutics, Inc. and NeuroMetrix, Inc. have P/E ratios of -2.0072 and -1.2085, respectively, suggesting that SINTX is relatively better positioned among its risky peers but still reflects significant financial challenges. Recent stock performance shows that while SINTX had a strong 1-month return of 32.70%, it lagged behind the S&P 500's 2.33% return over the same period, reinforcing the notion of its overvaluation amidst a broader market recovery.

Is SINTX Technologies, Inc. technically bullish or bearish?

As of September 4, 2025, SINTX Technologies, Inc. shows a bullish technical trend with strong weekly indicators, despite mixed monthly signals, and has outperformed the S&P 500 recently, although it has significantly underperformed over the past three years.

As of 4 September 2025, the technical trend for SINTX Technologies, Inc. has changed from mildly bullish to bullish. The weekly MACD is bullish, and the daily moving averages also indicate a bullish stance. However, the monthly MACD is only mildly bullish, and the Bollinger Bands show a mixed signal with weekly mildly bullish and monthly mildly bearish readings. The KST is bullish on the weekly and mildly bullish on the monthly, while the OBV is bullish monthly but only mildly bullish weekly. Dow Theory presents a mildly bearish view on the weekly but mildly bullish on the monthly.<BR><BR>In terms of performance, SINTX has outperformed the S&P 500 over the past month with a return of 32.70% compared to the S&P's 2.33%, and it has also shown a positive year-to-date return of 20.57% versus the S&P's 12.22%. However, over longer periods, the stock has significantly underperformed, with a 3-year return of -99.95% compared to the S&P's 70.41%.<BR><BR>Overall, the current technical stance is bullish, driven by strong weekly indicators, despite some mixed signals in the monthly data.